Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?

The market access process in the Netherlands can be very special, especially for medical devices. Besides standard reimbursement processes with evidence-based medicine assessments, there are also more pragmatic pathways available. How do these work and what needs to be considered… Continue Reading